Stockwatch: A healthcare share with recovery potential

Stockwatch: A healthcare share with recovery potential

This AIM stock benefits from healthcare demographics, but Edmond Jackson asks whether that's sufficient to outweigh cyclical risk.


This share was a tiddler when Edmond Jackson backed it in 2014. It's up 960% since then but remains 'very well-placed to benefit' in a rapidly growing industry.


It's already been a great call for Edmond Jackson, but this company has a new CEO and there's still significant upside potential.


Despite departing from his usual focus on fundamentals, Edmond Jackson believes this company is master of its own destiny and could go higher still.


A second upgrade in six months reflects momentum at this AIM-listed high-flyer. Edmond Jackson also believes there's less downside risk if markets turn unstable.


Both a serious institution and the chairman are stakebuilding in this firm, which might imply an early turning point for sentiment, argues Edmond Jackson.


This small firm's track record should continue to improve, believes Edmond Jackson, and better top line growth should reward investors who tuck the stock away.


This share has taken a big blow recently, but there is still an interesting story here. Edmond Jackson discusses the current dilemma.


If its broker's 2018 forecasts are correct, this AIM stock trades on a whopping 50% discount to NAV and has an attractive yield, says Edmond Jackson.


Edmond Jackson reckons this consumer discretionary stock rates a "long-term buy", but there are caveats to consider before rushing in.


The investment rationale with this pensions specialist is speculative, admits Edmond Jackson, but it's a business that's going places.


There's volatility ahead for this retailer and its rating could ease. Edmond Jackson reckons taking profits could be a shrewd move.


He's already made a 58% profit on this AIM-listed company, but Edmond Jackson still likes growth prosepcts and a well-covered 4% yield.


There's massive longer-term potential here as operational gearing kicks in, argues Edmond Jackson.


As a company able to benefit from a Brexit scenario, this luxury goods maker merits renewed attention and long-term buying interest, says Edmond Jackson.


As a long-term speculative play, it looks likely this AIM-listed firm will end up as part of a larger group, according to Edmond Jackson.   


This share has quadrupled since Edmond Jackson first covered it and there's still lots to like here, but what should investors do now?


This is a relatively small yet well-established business with a major opportunity, argues Edmond Jackson. Its US business also offers potential for upgrades.


It's been a game of Snakes and Ladders at this small-cap, but Edmond Jackson thinks a string of profit warnings is over and that earnings estimates are conservative.


This stock could 'easily double', said Edmond Jackson last year. It has, but there's still plenty of long-term upside potential.


It's intriguing how this tiddler's finance director is tucking stock away in his ISA, says Edmond Jackson.